ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Bin Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardio and Respiratory Medicine, Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, Papworth Road, Cambrid…. Hauptthemen laut MEDLINE: Endothelial Cells, Polyamines, Membrane Transport Proteins, Adenosine Triphosphatases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Cambridge Trust International Scholarship, Great Britain-China Educational Trust.
Abstract (Originalsprache)
Aims
Potential loss-of-function variants of ATP13A3, the gene encoding a P5B-type transport ATPase of undefined function, were recently identified in patients with pulmonary arterial hypertension (PAH). ATP13A3 is implicated in polyamine transport but its function has not been fully elucidated. In this study, we sought to determine the biological function of ATP13A3 in vascular endothelial cells (ECs) and how PAH-associated variants may contribute to disease pathogenesis. Methods and results We studied the impact of ATP13A3 deficiency and overexpression in EC models [human pulmonary ECs, blood outgrowth ECs (BOECs), and human microvascular EC 1], including a PAH patient–derived BOEC line harbouring an ATP13A3 variant (LK726X). We also generated mice harbouring an Atp13a3 variant analogous to a human disease–associated variant to establish whether these mice develop PAH. ATP13A3 localized to the recycling endosomes of human ECs. Knockdown of ATP13A3 in ECs generally reduced the basal polyamine content and altered the expression of enzymes involved in polyamine metabolism. Conversely, overexpression of wild-type ATP13A3 increased polyamine uptake. Functionally, loss of ATP13A3 was associated with reduced EC proliferation, increased apoptosis in serum starvation, and increased monolayer permeability to thrombin. The assessment of five PAH-associated missense ATP13A3 variants (L675V, M850I, V855M, R858H, and L956P) confirmed loss-of-function phenotypes represented by impaired polyamine transport and dysregulated EC function. Furthermore, mice carrying a heterozygous germline Atp13a3 frameshift variant representing a human variant spontaneously developed a PAH phenotype, with increased pulmonary pressures, right ventricular remodelling, and muscularization of pulmonary vessels.
Conclusion
We identify ATP13A3 as a polyamine transporter controlling polyamine homeostasis in ECs, a deficiency of which leads to EC dysfunction and predisposes to PAH. This suggests a need for targeted therapies to alleviate the imbalances in polyamine homeostasis and EC dysfunction in PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Cardio and Respiratory Medicine, Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, Papworth Road, Cambridge CB2 0BB, UK.
- Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Box 802, 3000 Leuven, Belgium.
- Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
- Division of Gastroenterology and Hepatology, Department of Medicine, Hills Road, Cambridge CB2 0QQ, UK.
- Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK.
- Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Herestraat 49, Box 1023, 3000 Leuven, Belgium.
ORCID-Profile: Paul D Upton
Förderung
- China Scholarship Council
- Cambridge Trust International Scholarship
- Great Britain-China Educational Trust
- Henry Lester Trust and Leche Trust
- Fonds voor Wetenschappelijk Onderzoek
- Flanders
- Marie Sklodowska-Curie Postdoctoral Research
- BHF Programme
Zitieren
APA
Liu, B., Azfar, M., Legchenko, E., West, J. A., Martin, S., Van den Haute, C., Baekelandt, V., Wharton, J., Howard, L., Wilkins, M. R., Vangheluwe, P., Morrell, N. W., & Upton, P. D. (2024). ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae068
Vancouver
Liu B, Azfar M, Legchenko E, West JA, Martin S, Van den Haute C, et al. ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae068
BibTeX
@article{Liu2024,
author = {Liu, Bin and Azfar, Mujahid and Legchenko, Ekaterina and West, James A and Martin, Shaun and Van den Haute, Chris and Baekelandt, Veerle and Wharton, John and Howard, Luke and Wilkins, Martin R and Vangheluwe, Peter and Morrell, Nicholas W and Upton, Paul D},
title = {ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae068}
}
EUVIMED